tiprankstipranks
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP

Crispr Therapeutics AG (CRSP) Income Statement

7,401 Followers

Crispr Therapeutics AG Income Statement

Last quarter (Q4 2023), Crispr Therapeutics AG's total revenue was $201.21M, an increase of 3353333.33% from the same quarter last year. In Q4, Crispr Therapeutics AG's net income was $-131.15M. See Crispr Therapeutics AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 371.21M$ 371.21M$ 436.00K$ 914.96M$ 719.00K$ 289.59M
Cost of Revenue
------
Gross Profit
$ 371.21M$ 371.21M$ -109.81M$ 914.96M--
Operating Expense
$ 593.74M$ 593.74M$ -563.35M$ -541.43M$ 355.15M$ 242.85M
Operating Income
$ -133.27M$ -222.54M$ -673.16M$ 373.53M$ -354.44M$ 46.74M
Net Non Operating Interest Income Expense
------
Other Income Expense
$ -71.82M$ -71.82M$ -22.66M$ -6.00M$ 6.38M$ 20.57M
Pretax Income
$ -150.72M$ -150.72M$ -650.50M$ 379.53M$ -348.06M$ 67.31M
Tax Provision
$ 2.89M$ 2.89M$ -325.00K$ 1.87M$ 809.00K$ 448.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -327.27M$ -153.61M$ -650.17M$ 377.66M$ -348.87M$ 66.86M
Basic EPS
$ -1.94$ -1.94$ -8.36$ 4.97$ -5.29$ 1.23
Diluted EPS
$ -1.94$ -1.94$ -8.36$ 4.70$ -5.29$ 1.17
Basic Average Shares
$ 316.88M$ 79.22M$ 77.75M$ 75.95M$ 65.95M$ 56.93M
Diluted Average Shares
$ 316.88M$ 79.22M$ 77.75M$ 80.39M$ 65.95M$ 56.93M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 593.74M$ 593.74M$ 674.36M$ -541.43M$ 355.15M$ 242.85M
Net Income From Continuing And Discontinued Operation
$ -153.61M$ -153.61M$ -650.17M$ 377.66M$ -348.87M$ 66.86M
Normalized Income
$ -78.19M$ -119.07M$ -650.83M-$ -348.87M$ 66.86M
Interest Expense
------
EBIT
$ -150.72M$ -150.72M$ -650.50M$ 379.53M$ -354.44M$ 46.74M
EBITDA
$ -130.88M$ -130.88M$ -626.33M$ 397.48M$ -345.25M$ 51.47M
Currency in USD

Crispr Therapeutics AG Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis